Wright; Jim A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wright; Jim A..The latest application filed is for "use of interleukin 17e for the treatment of cancer".

Company Profile

0.10.13

Wright; Jim A. - Oakville CA
Wright; Jim A. - Toronto CA
Wright; Jim A. - Winnipeg CA
Wright; Jim A. - Aurora CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of interleukin 17E for the treatment of cancer Grant 8,287,851 - Wright , et al. October 16, 2	2012-10-16
2-indolyl imidazo [4,5-d] phenanthroline derivatives and their use in the treatment of cancer Grant 8,148,392 - Huesca , et al. April 3, 2	2012-04-03
Use Of Interleukin 17e For The Treatment Of Cancer App 20110158936 - Wright; Jim A. ; et al.	2011-06-30
Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in the treatment of cancer Grant 7,968,526 - Wright , et al. June 28, 2	2011-06-28
Small Interfering Rna Molecules Against Ribonucleotide Reductase And Uses Thereof App 20100204305 - YOUNG; Aiping H. ; et al.	2010-08-12
Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2 and Uses Thereof in the Treatment of Cancer App 20100197766 - WRIGHT; Jim A. ; et al.	2010-08-05
2-Indolyl Imidazo [4,5-d] Phenanthroline Derivatives and Their Use in the Treatment for Cancer App 20100168417 - Huesca; Mario ; et al.	2010-07-01
Antisense Oligonucleotides Directed to Ribonucleotide Reducatase R2 and Uses Thereof in Combination Therapies for the Treatment of Cancer App 20080311126 - Young; Aiping H. ; et al.	2008-12-18
Small Interfering Rna Molecules Against Ribonucleotide Reductase and Uses Thereof App 20080255065 - Young; Aiping H. ; et al.	2008-10-16
Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase Grant 7,405,205 - Wright , et al. July 29, 2	2008-07-29
Antisense Oligonucleotides Directed to Ribonucleotide Reductase R1 and Uses Thereof in the Treatment of Cancer App 20070274947 - Young; Aiping H. ; et al.	2007-11-29
Oligonucleotides from the untranslated regions of housekeeping genes and methods of using same to modulate cell growth Grant 7,223,849 - Wright , et al. May 29, 2	2007-05-29
Vector utilizing ribonuclease reductase UTR and use for inhibiting neoplastic cells App 20070032442 - Wright; Jim A. ; et al.	2007-02-08
Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth Grant 7,087,580 - Wright , et al. August 8, 2	2006-08-08
Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase App 20040009948 - Wright, Jim A. ; et al.	2004-01-15
Antisense oligonucleotide sequences as inhibitors of microorganisms Grant 6,610,539 - Wright , et al. August 26, 2	2003-08-26
Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth Grant 6,566,514 - Wright , et al.	2003-05-20
Suppression of malignancy utilizing ribonucleotide reductase R1 App 20030087866 - Wright, Jim A. ; et al.	2003-05-08
Neuropilin Antisense Oligonucleotide Sequences And Methods Of Using Same To Modulate Cell Growth App 20030083274 - WRIGHT, JIM A. ; et al.	2003-05-01
Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to modulate cell growth App 20020187954 - Wright, Jim A. ; et al.	2002-12-12
Supression Of Malignancy Utilizing Ribonucleotide Reductase R1 App 20020004488 - WRIGHT, JIM A. ; et al.	2002-01-10
Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase Grant 6,121,000 - Wright , et al. September 19, 2	2000-09-19
Antitumor antisense sequences directed against ribonucleotide reductase Grant 5,998,383 - Wright , et al. December 7, 1	1999-12-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.